Abound Wealth Management’s TG Therapeutics TGTX Stock Holding History

Abound Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$193K	Hold	3,506	–	–	0.04%	101
2026 Q1	$116K	Hold	3,506	–	–	0.03%	137
2025 Q4	$105K	Hold	3,506	–	–	0.02%	134
2025 Q3	$127K	Hold	3,506	–	–	0.03%	113
2025 Q2	$126K	Buy	3,506 +3,498	+43,725%	+$130K	0.04%	105
2025 Q1	$316	Sell	8 -2	-20%	-$67	﹤0.01%	865
2024 Q4	$301	Hold	10	–	–	﹤0.01%	894
2024 Q3	$234	Buy	+10	New	+$218	﹤0.01%	1076

Other funds holding TGTX

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Portside Wealth Group Provo, Utah $856M AUM 26.82% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Trust Company of the South Greensboro, North Carolina $710M AUM 26.71% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return